Decaudin, Didier <br/><br/>
Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.  [electronic resource] 

 -  Journal of the National Cancer Institute  Apr 2004 
 - 636-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djh108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Chromatography, High Pressure Liquid<br/>Drug Administration Schedule<br/>Estrogen Receptor Modulators--administration & dosage<br/>Feasibility Studies<br/>Humans<br/>Multiple Myeloma--drug therapy<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Tamoxifen--administration & dosage<br/>Treatment Outcome